The Relationships Between MASLD, Extrahepatic Multimorbidity, and All-Cause Mortality in the UK Biobank Cohort - Top-Institutions - MDSpire

The Relationships Between MASLD, Extrahepatic Multimorbidity, and All-Cause Mortality in the UK Biobank Cohort

  • By

  • Qi Feng

  • Chioma N Izzi-Engbeaya

  • Andrea D Branch

  • Benjamin H Mullish

  • Pinelopi Manousou

  • Mark Woodward

  • June 10, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Hepatology
    • Metabolic Disease
    • Epidemiology

  • #2

    University of California, San Diego (UCSD) - NAFLD Research Center
    University of California, San Diego (UCSD) - NAFLD Research Center

    San Diego, California

    Key Differentiators

    • Hepatology
    • Metabolic Syndrome
    • Translational Research

  • #3

    Imperial College London
    Imperial College London

    London, England

    Key Differentiators

    • Hepatology
    • Population Health
    • Epidemiology

  • #4

    Mount Sinai Health System
    Mount Sinai Health System

    New York, New York

    Key Differentiators

    • Hepatology
    • Metabolic Disease
    • Clinical Research

  • #5

    University of Michigan
    University of Michigan

    Ann Arbor, Michigan

    Key Differentiators

    • Hepatology
    • Metabolic Disorders
    • Epidemiology

Original Source(s)

The Relationships Between MASLD, Extrahepatic Multimorbidity, and All-Cause Mortality in the UK Biobank Cohort

  • by Qi Feng, Chioma N Izzi-Engbeaya, Andrea D Branch, Benjamin H Mullish, Pinelopi Manousou, Mark Woodward

  • June 10, 2025

Related Content

A FAERS database study on visual impairment adverse events associated with three long-acting insulin analogues

Borderline Liver Enzyme Patterns and Their Metabolic–Inflammatory Signatures: An Observational Outpatient Study

Hidden Gene Error Found in Fatty Liver

Exome sequencing reveals a rare MET mutation in liver disease

  • March 20, 2026

  • 2 min